Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-06 3:02 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -1,811,505 (Position Closed) | View |
| 2023-01-31 2:18 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FRANKLIN RESOURCES INC BEN | 0 0% | -1,252,142 (Position Closed) | View |
| 2023-01-09 4:19 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I LLC | 3,408,081 9.9% | 3,408,081 (New Position) | View |
| 2023-01-09 4:06 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Venrock Healthcare Capital Partners III L.P. | 2,916,667 8.6% | 2,916,667 (New Position) | View |
| 2023-01-06 1:46 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | BlackRock Inc. BLK | 1,572,421 4.6% | 67,801 (+4.51%) | View |
| 2022-12-30 2:15 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 3,238,859 9.5% | 1,666,667 (+106.01%) | View |
| 2022-08-15 5:12 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | RA CAPITAL MANAGEMENT L.P. | 0 0% | -1,930,322 (Position Closed) | View |
| 2022-05-26 4:00 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | TANG CAPITAL PARTNERS LP | 1,400,000 5.7% | 1,400,000 (New Position) | View |
| 2022-05-18 4:03 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | GREAT POINT PARTNERS LLC | 1,280,000 5.22% | 1,280,000 (New Position) | View |
| 2022-02-14 4:32 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Ikarian Capital LLC | 36,576 0.2% | -1,027,385 (-96.56%) | View |
| 2022-02-14 4:11 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | RA CAPITAL MANAGEMENT L.P. | 1,930,322 7.9% | 530,833 (+37.93%) | View |
| 2022-02-14 11:53 am Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | EVENTIDE ASSET MANAGEMENT LLC | 138,821 0.6% | -1,541,179 (-91.74%) | View |
| 2022-02-14 08:57 am Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Deep Track Capital LP | 1,500,000 6.13% | 233,116 (+18.40%) | View |
| 2022-02-11 5:28 pm Unchanged | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Vivo Ventures VI LLC | 1,383,179 5.7% | 0 (Unchanged) | View |
| 2022-02-11 5:03 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,746,300 7.1% | 449,848 (+34.70%) | View |
| 2022-02-11 4:09 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Flynn James E | 1,175,131 4.8% | -630,906 (-34.93%) | View |
| 2022-02-10 5:11 pm Sale | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Longwood Fund II L.P. | 7,801 0.03% | -926,683 (-99.17%) | View |
| 2022-02-04 2:31 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | FRANKLIN RESOURCES INC BEN | 1,252,142 5.1% | 1,252,142 (New Position) | View |
| 2022-02-04 09:27 am Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | WELLINGTON MANAGEMENT GROUP LLP | 1,811,505 7.4% | 1,811,505 (New Position) | View |
| 2022-01-31 5:49 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | BlackRock Inc. BLK | 1,504,620 6.1% | 391,240 (+35.14%) | View |